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Abstract: Proper embryonic development depends upon regulatory signals from the reproductive tract called embryokines. This
review uses the cow as a model to understand the developmental processes controlled by embryokines. The focus is on 3 embryokines
that have been shown to increase competence of embryos to survive after transfer to recipients: CSF2, IGF1, and DKK1. Together,
these molecules regulate key events required for development of the embryo to the blastocyst stage including proliferation (enhanced
by IGF1), development of the inner cell mass (regulated by CSF2), control of differentiation (modified by DKK1), and inhibition of
apoptosis and stress-mediated developmental arrest (IGF1 and CSF2).
Key words: Embryo, embryokine, colony stimulating factor 2, insulin-like growth factor-1, dickkopf 1

1. Importance of maternal signals for development of
the bovine blastocyst
The zygote contains within its genome and epigenome the
program to direct development through the embryonic,
fetal, and postnatal periods. The execution of that program
is dependent on the embryo’s nongenetic inheritance from
the oocyte and sperm (1,2) as well as on the environment
in which development proceeds. Variation in the maternal
environment can affect the ability of the preimplantation
embryo to establish pregnancy. In cattle, the focus of this
review, competence of the preimplantation embryo for
growth and survival can be affected by maternal parity
(3), lactational status (4), and circulating concentrations
of progesterone (5). Moreover, patterns of gene expression
in the endometrium are associated with survival of an
embryo transferred to the uterus in the next ovulatory
cycle (6,7).
Development of the bovine embryo to the blastocyst
in the absence of maternal signals (i.e. through in vitro
production procedures) results in embryos with aberrant
gene expression (8,9), lipid content (10,11), DNA
methylation (12), and, as shown in the Table, reduced
competence to establish pregnancy after transfer into
recipients (13–17). Additionally, an increased proportion
of embryos produced in vitro have developmental

abnormalities that lead to increased neonatal death losses
(18–20). Some of the problems with the in vitro-produced
embryo could result from selection of incompetent
oocytes or inadequate oocyte maturation. However,
the importance of the maternal environment during
development is indicated by observations that transfer of
in vitro-produced embryos to the oviduct after fertilization
limits some of the abnormalities associated with in vitro
production (9,21).
One function of the reproductive tract is to secrete
bioactive molecules that regulate the embryo, oviduct,
or endometrium. Genes for 115 ligands expressed in
the endometrium had the corresponding receptor gene
expressed by the embryo (22). Regulatory molecules
produced by the oviduct and endometrium, which include
hormones, growth factors, and cytokines, are referred to
as embryokines when they function to regulate embryonic
growth and development (23).
It is likely that some of the variation in the ability of
the reproductive tract to support embryonic development
represents variation in secretion of embryokines. Indeed,
several genes that were overexpressed in the endometrium
of cows that subsequently became pregnant after embryo
transfer as compared to cows that did not establish
pregnancy are potential embryokines. These include NGF,
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Table. Differences in pregnancy rate after transfer of fresh embryos produced in vivo or in vitro.
Pregnancy rate
Recipient type

Day of pregnancy
diagnosis

Embryos
produced in vivo

Embryos
produced in vitro

Reference

Heifers

53

79% (n = 19)

37% (n = 19)**

13

Beef and dairy heifers

50

55% (n = 199)

37% (n = 90)**

14

Bos taurus × B. indicus heifers

60

42% (n = 289)

34% (n = 910)*

15

Bos taurus × B. indicus nonlactating cows and heifers 30

59% (n = 90)

31% (n = 87)***

16

Holstein cows, nonlactating

50% (n = 115)

43% (n = 145)

17

98

*: P < 0.05; **: P < 0.01; ***: P < 0.001.

VEGFB, and WNT11 (6) and CSF3, CXCL2, IL18, IL1B,
and TNFSF13 (7). Among the genes upregulated in heifers
of high fertility versus those of lower fertility were CXCL2,
DKK1, and SFRP4 (24).
Despite the importance of secretory molecules from
the reproductive tract for control of early embryonic
development, little is known about how specific
embryokines regulate development of the embryo. The
purpose of this review is to use the bovine as a model to
understand the developmental processes controlled by
embryokines that increase competence of the embryo
to develop successfully to term. Focus will be on those
embryokines in which effects on competence of embryos
to survive after transfer to recipients have been examined:
CSF2, IGF1, and DKK1. These molecules are not the
only maternally derived regulatory molecules that can
affect preimplantation development in the bovine. Other
examples include activin (25,26), ILB1 (27), LIF (28),
TGFB (28), FGF2 (28,29), and EGF (30). However, there
is sufficient information about the role of CSF2, IGF1,
and DKK1 on the bovine embryo to allow identification
of functions regulated by these molecules that are likely
important for developmental competence of the embryo.
Among these functions is stimulation of proliferation,
development of the inner cell mass (ICM), control of
differentiation, and inhibition of apoptosis and stressmediated developmental arrest.
2. Colony stimulating factor 2
Also called granulocyte-macrophage colony stimulating
factor, CSF2 was discovered as a hematopoietic growth
factor that controls development and function of
granulocytes and macrophages (31). The cytokine is
produced by several cell types, usually in response to an
inflammatory signal, including fibroblasts, smooth muscle
cells, endothelial cells, and monocytes (32). Moreover,
CSF2 acts on a variety of cells to stimulate growth, block
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apoptosis, regulate chemotaxis, and induce release of
bioactive molecules (33).
One of the sites of synthesis of CSF2 is the oviduct and
endometrium, with greatest localization in the luminal
epithelium (34–36). There is little cyclic variation in labeling
intensity of CSF2 in the endometrium (34,35). Pregnancy
may modify secretion of CSF2 because intensity of
immunolabeling in the endometrial stroma was increased
at day 7 in pregnant cows as compared to cyclic cows and
labeling in the luminal epithelium of the endometrium was
increased by intrauterine treatment with the embryonic
secretory product IFNT (35). Immunoreactive protein and
mRNA for CSF2 in the oviduct was reduced in obese cows
(36), so environmental factors may also modify secretion
of the cytokine.
In the cow (37,38), as well as in the mouse (39) and
human (40), treatment of embryos in vitro with CSF2
increases the proportion of embryos that survive after
transfer to recipient females. Results of experiments with
cattle are summarized in Figure 1. CSF2 increased the
percent of recipients diagnosed as pregnant at 30–35 days
of gestation when the cytokine was administered from day
5 to 7 of development (i.e. when the embryo was a morula
or blastocyst), but not when treatment was from day 1
to 7 after development (i.e. from the zygote to blastocyst
stage). It is not really known whether the duration of
CSF2 treatment is crucial for the change in embryonic
function leading to increased pregnancy rate. That it may
not be is indicated by the observation that CSF2 reduced
fetal loss after initial pregnancy diagnosis when embryos
were exposed to CSF2 from either day 5 to 7 (in 1 of 2
experiments examined) or day 1 to 7. What is more likely
is that the small sample size for each experiment created
some variability in response.
There are several changes in the embryo caused by
CSF2 that could potentially be responsible for the increased
competence to establish pregnancy. Blastocysts produced
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Figure 1. Culture with CSF2, IGF1, and DKK1 improves survival of in vitro-produced embryos after transfer into recipients. Data
represent pregnancy and calving rates. Black bars represent cows receiving control embryos while open bars represent cows receiving
embryos treated with CSF2 from day 1 to 7 or 5 to 7 of development, DKK1 from day 5 to 7 of development, or IGF1 for the first 7 or 8
days of development. Significant differences are indicated by asterisks (*: P < 0.05; **: P < 0.01).

in the presence of CSF2 have increased numbers of cells in
the ICM (37). Moreover, CSF2 improves survival of isolated
ICM maintained in culture (41). These actions of CSF2 on
the ICM could be important for embryonic survival since
25% or more of in vitro-produced embryos at days 14–17
of gestation are reported to be without the embryonic
disk derived from the ICM (42–44). CSF2 also has actions
on development of the trophoblast because embryos
collected at day 15 have more extensive development of
extraembryonic membranes when exposed to CSF2 from
day 5 to 7 of development than when not treated with
CSF2 (44). This action of CSF2 depends on sex, with CSF2
increasing the length of male embryos and decreasing the
length of female embryos (45).

Some of the actions of CSF2 on the embryo could be
mediated by inhibition of apoptosis. Culture with CSF2
altered expression of several genes involved in apoptosis
and reduced the increase in apoptosis caused by exposure
of embryos to heat shock (46). Interestingly, CSF2 increases
the percent of embryos becoming blastocysts only when
development in control embryos is low (41). This result
could indicate that CSF2 is reversing some aspects of
cellular stress that lower development.
CSF2 also altered expression of 42 genes involved in
the developmental process ontology of DAVID, including
several genes whose change in expression was interpreted
to indicate promotion of mesoderm formation and
regulation of WNT signaling (46).
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The prototypical signal transduction system for
CSF2 involves a low-affinity α subunit (CSF2RA) and a
high-affinity β subunit (CSF2RB) (47). In the cow (41),
as in other species (48–50), CSF2RA is expressed in the
preimplantation embryo but expression of CSF2RB is
undetectable or nearly so. It is likely, therefore, that CSF2
signaling in the embryo involves an unknown pathway that
is independent of CSF2RB. In Xenopus oocytes, signaling
through CSFRA is possible through a mechanism involving
H2O2 generation and phosphatidylinositol 3-kinase (51).
3. Insulin-like growth factor 1
Several features of its biology make it difficult to
understand the actions of IGF1 in the reproductive tract.
The gene itself is subject to differential splicing and the
protein can be modified after translation by proteolysis
and glycosylation (52). IGF1 is part of a larger family of
proteins including INS and IGF2, and each can interact
with each other’s receptors (INSR, IGF1R, and IGF2R)
(53). The effective concentration of IGF1 and IGF2 for
receptor interactions depends upon concentrations of 6
separate IGF-binding proteins, which prevent receptor
binding while also increasing the half-life of IGF1(52).
IGF1 is both a hormone, being released by the liver to
mediate actions of somatotropin, and a locally produced
growth factor. Accordingly, IGF1 concentrations in
the lumen of the reproductive tract depend upon local
synthesis and transudate from the blood. The extent to
which changes in circulating concentrations of IGF1
modify local amounts in oviductal or uterine fluids is not
well established. There were nonsignificant increases in
amounts of IGF1 in uterine lumen of cows in response to
administration of bovine somatotropin (54,55).
In the oviduct, local expression of IGF1 occurs in the
endosalpinx of the ampulla and isthmus (56,57), particularly
in the stroma underneath the luminal epithelium (56).
Protein localization, in contrast, is greatest in the luminal
epithelium (57,58). Expression peaks around estrus and
declines thereafter (56,57). IGF1 is also expressed in the
uterine endometrium (55,59,60). There is little variation in
expression between days 5 and 16 after estrus in cyclic or
pregnant cows (61). Endometrial expression of IGF1 was
not regulated by somatotropin in 2 experiments (59,60).
In a third study, expression of IGF1 as well as IGFBP2 and
IGFBP3 was increased in endometrium of cyclic but not
pregnant animals at day 17 after estrus (55).
The bovine embryo expresses IGF1R during early
development, with steady-state amounts of IGF1R mRNA
decreasing from the zygote stage to day 3 after fertilization
and then increasing steadily to the blastocyst stage (62).
Two major signal transduction systems activated by
binding of IGF1 to the IGF1R are the MAPK pathway,
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which leads to increases in proliferation, growth, and
differentiation, and the PI3K/AKT pathway, which inhibits
apoptosis (63). Actions of IGF1 on the preimplantation
embryo indicate that both MAPK and PI3K/AKT pathways
are activated (Figure 2). Culture with IGF1 increases the
percent of embryos capable of developing to the blastocyst
stage (28,30,64–69). This action of IGF1 probably
involves increased proliferation because the cell number
of day 6 morulae was increased by IGF1 (70). Effects on
development could be blocked with antibody to IGF1R
(64) and an inhibitor of MAPK activation (69,70). IGF1
also blocks activation of apoptosis caused by exposure
to heat shock (70,71) or the prooxidant menadione (72).
Antiapoptotic actions of IGF1 in heat-shocked embryos

Figure 2. Signal transduction pathways for actions of IGF1 on
the preimplantation bovine embryo. Studies with chemical
inhibitors indicate actions of IGF1 on cell number and
competence to develop to the blastocyst stage are mediated by
the MAPK pathway while inhibition of apoptosis is mediated by
the PI3K/AKT pathway.
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are mediated by PI3K/AKT since reduction in apoptosis
was blocked by administration of inhibitors of PI3K or
AKT (70,71).
Another action of IGF1 is protection from cellular
stress. In particular, IGF1 blocks antidevelopmental
effects of heat shock (70,73,74) and menadione (72). There
is also a report that IGF1 increased the proportion of
frozen-thawed morulae that developed to the blastocyst
stage (75). This effect could represent prevention of
damage associated with cryopreservation or actions of
IGF1 to increase development. IGF1 increases transcript
abundance for several genes involved in cellular protection
including those involved in regulation of apoptosis and
protection against free radicals (74). The cytoprotective
effect of IGF1 is probably not the sole result of inhibition
of apoptosis. This is so because thermoprotective actions
of IGF1 on development were not blocked with a PI3K
inhibitor and could not be mimicked by addition of a
caspase-3 inhibitor to block apoptosis (70).
Early in development, the embryo is refractory to IGF1.
Addition of IGF1 at day 4 after fertilization increased the
percent of embryos becoming blastocysts but there was no
effect of IGF1 from fertilization to day 4 (69). Similarly,
IGF1 protected embryos from heat shock at day 5 of
development but not 2-cell embryos (74). Developmental
acquisition of responsiveness to IGF1 could reflect changes
in IGF1R (62), the need for an active embryonic genome
[which occurs at the 8–16 cell stage in the cow (76)], or
regulation of key events associated with formation of the
morula or blastocyst.
Blastocysts formed in the presence of IGF1 have
increased capacity to establish pregnancy when transferred
to females (37,77,78). However, as shown in Figure 1, this
property has only been shown to occur when recipients
were exposed to heat stress. The reason for this interaction
between IGF1 treatment and recipient type is not known.
It is possible that IGF1-treated embryos are better able to
resist maternal heat stress. However, the bovine embryo has
gained resistance to maternal heat stress by the blastocyst
stage of development (79) and there is little or no seasonal
variation in pregnancy rate to embryo transfer (80). It is
also not clear what properties of the blastocyst contribute
to its increased propensity for posttransfer survival. In
some experiments, blastocysts treated with IGF1 had
increased cell number (67) and reduced proportion of
cells that were apoptotic (66,67), whereas differences in
cell number (66,81) and apoptosis (81) were not seen in
other experiments.
Administration of somatotropin to embryo transfer
recipients also increases embryonic survival (82). However,
this action could represent direct actions of somatotropin
on embryonic development (65) as well as increased IGF1
in uterine lumen (54,55).

4. Dickkopf 1 and regulation of WNT signaling
The WNT family of regulatory molecules plays important
roles in development, oncogenesis, angiogenesis,
inflammation, and wound repair (83–86). It is likely
that WNTs also regulate the preimplantation embryo.
Examination of a microarray database of mRNA from
bovine morulae revealed expression of several WNT genes
(WNT1, WNT2B, WNT3A, WNT4, WNT5A, WNT5B,
WNT7B, WNT8A, WNT8B, WNT9A, WNT9B, WNT10A,
WNT10B, WNT11, and WNT16) and FZD receptor genes
(FZD1, FZD2, FZD3, FZD4, FZD5, FZD6, FZD7, FZD8,
FZD9, and FZD10) (87). WNT signaling is complex and
characterized by cross-talk between signaling pathways.
The most well-characterized signaling cascade is the
canonical or β-catenin-dependent pathway. Activation
of this pathway requires binding of WNT to FZD and
the coreceptor LRP5 or LRP6. A series of downstream
events leads to inhibition of proteolysis of β-catenin and
its translocation to the nucleus where it interacts with
TCF and LEF family transcription factors to regulate gene
expression. There are a variety of other signaling cascades
activated by WNTs termed noncanonical pathways (83–
86). Some of these pathways use FZD as a receptor (planar
cell polarity and Ca++-mediated signaling) while other
pathways use other receptors such as receptor tyrosine
kinase orphan receptor and receptor tyrosine kinase.
Often, activations of canonical and noncanonical pathways
exert opposite effects on cellular function (84,85).
Overactivation of the canonical WNT signaling
pathway can inhibit development of the bovine embryo.
Culture of bovine embryos with an agonist of canonical
WNT signaling called 2-amino-4-(3,4-(methylenedioxy)
b e n z y l am i no ) - 6 - ( 3 - me t hox y phe ny l ) py r i m i d i ne
(AMBMP) reduced the percentage of embryos that
developed to the blastocyst stage and reduced numbers of
blastomeres in those blastocysts that did form (87). Cell
number was reduced more for TE cells than for cells in
the ICM.
WNT signaling in the embryo may be regulated by
a secretory inhibitor of canonical WNT signaling called
DKK1. Expressed in the bovine endometrium (24,88),
DKK1 can bind to LRP5/6 and, in the presence of the
transmembrane protein KREMEN, cause its internalization
and destruction and thereby prevent formation of the
WNT-FZD-LRP5/6 complex (86,89,90). In addition,
DKK1 can activate the planar cell polarity pathway (91–
93). Addition of DKK1 blocks the inhibitory actions
of AMBMP on development (87). In addition, culture
of embryos with DKK1 from day 5 to 8 of development
increased the percent of cells in the blastocyst labeled
as TE, decreased the percent of cells classified as ICM
(CDX2-), and increased the percent of cells in the ICM
classified as hypoblasts (cells positive for labeling with the
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transcription factor GATA6 and negative for labeling with
CDX2 and NANOG) (38). These actions of DKK1 are in
contrast to the inhibition of TE cells caused by activation
of WNT signaling (87).
Based on these experiments, it has been proposed
(38) that DKK1 facilitates cell fate decisions in the early
embryo, resulting in blastocysts with a higher proportion
of embryonic cells committed to the TE fate and of ICM
cells differentiating into the hypoblast lineage. These effects
of DKK1 likely result from a shift between pluripotency
and differentiation, and are not reflective of an increased
total cell number because DKK1 does not promote cell
proliferation in the early embryo (38).
Like for CSF2 and IGF1, culture of embryos with DKK1
from day 5 to 7 after fertilization improves competence
of embryos to establish pregnancy (38). Pregnancy rates
at day 32 after ovulation were higher for cows receiving
embryos treated with DKK1 than for cows receiving
control embryos (Figure 1). The greater pregnancy rate
at day 32 for cows receiving embryos treated with DKK1
or CSF2 persisted but differences at calving became
nonsignificant (Figure 1).

It is possible that physiological variation in DKK1
expression in the endometrium contributes to variation in
fertility between cows. Expression of DKK1 is reduced in
the endometrium of lactating cows (88) and was lower in
inherently subfertile heifers than in more fertile ones (24).
5. Conclusions
Many events must be properly executed for a cleavagestage embryo to develop to a blastocyst-stage embryo
capable of establishing pregnancy. Among these is
proliferation of blastomeres, differentiation of TE cells
from the outer cells of the morula, formation of the ICM,
and differentiation of specific cells in the ICM to hypoblast
with retention of pluripotency of the remaining cells of
the ICM (now the epiblast). Moreover, the embryo must
execute its developmental program while being protected
from adverse stimuli in its environment that could cause
apoptosis or other cellular damage inducing developmental
arrest. These events are regulated by the embryokines that
form the focus of this review (Figure 3). In particular,
growth of the embryo is enhanced by IGF1, regulation of
ICM cell number and capacity for survival is enhanced by

Figure 3. Events in the formation and development of the bovine blastocyst regulated by select embryokines. Development to the blastocyst
stage is increased by IGF1, at least in part because it increases cell proliferation. CSF2 affects development of the inner cell mass (ICM) so as
to increase its cell number and the ability of isolated ICM to survive in culture. In contrast, DKK1 promotes cell differentiation by promoting
development of the trophectoderm (TE) and hypoblast. Both CSF2 and IGF1 protect embryos from stimuli that could otherwise lead to
developmental arrest. Both block induction of apoptosis and IGF1 can also reduce apoptosis-independent cellular damage.
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CSF2, and differentiation of TE and hypoblast is facilitated
by DKK1. Moreover, both CSF2 and IGF1 inhibit induction
of apoptosis by proapoptotic stimuli. IGF1 can also reduce
apoptosis-independent damage to the embryo, at least that
caused by heat shock.
It remains to be determined whether actions of these
embryokines are indispensable for optimum development

or whether other secretory products of the reproductive
tract exert redundant actions. It will also be instructive to
determine whether variation between females in secretion
of CSF2, IGF1, or DKK1 is an important determinant of
fertility and whether manipulation of expression of the
genes for these embryokines can improve reproductive
function.

References
1.

Hansen PJ, Block J, Loureiro B, Bonilla L, Hendricks KE. Effects
of gamete source and culture conditions on the competence of
in vitro-produced embryos for post-transfer survival in cattle.
Reprod Fertil Dev 2010; 22: 59–66.

12.

Niemann H, Carnwath JW, Herrmann D, Wieczorek G,
Lemme E, Lucas-Hahn A, Olek S. DNA methylation patterns
reflect epigenetic reprogramming in bovine embryos. Cell
Reprogram 2010; 12: 33–42.

2.

Sirard MA. Factors affecting oocyte and embryo transcriptomes.
Reprod Domest Anim 2012; 47 (Suppl. 4): 148–155.

13.

3.

Berg DK, van Leeuwen J, Beaumont S, Berg M, Pfeffer PL.
Embryo loss in cattle between Days 7 and 16 of pregnancy.
Theriogenology 2010; 73: 250–260.

Farin PW, Farin CE. Transfer of bovine embryos produced in
vivo or in vitro: survival and fetal development. Biol Reprod
1995; 52: 676–682.

14.

Hasler JF, Bilby CR, Collier RJ, Denham SC, Lucy MC. Effect of
recombinant bovine somatotropin on superovulatory response
and recipient pregnancy rates in a commercial embryo transfer
program. Theriogenology 2003; 59: 1919–1928.

15.

Pontes JH, Nonato-Junior I, Sanches BV, Ereno-Junior JC,
Uvo S, Barreiros TR, Oliveira JA, Hasler JF, Seneda MM.
Comparison of embryo yield and pregnancy rate between in
vivo and in vitro methods in the same Nelore (Bos indicus)
donor cows. Theriogenology. 2009; 71: 690–697.

4.

Maillo V, Rizos D, Besenfelder U, Havlicek V, Kelly AK,
Garrett M, Lonergan P. Influence of lactation on metabolic
characteristics and embryo development in postpartum
Holstein dairy cows. J Dairy Sci 2012; 95: 3865–3876.

5.

Kenyon AG, Mendonça LG, Lopes G Jr, Lima JR, Santos JE,
Chebel RC. Minimal progesterone concentration required for
embryo survival after embryo transfer in lactating Holstein
cows. Anim Reprod Sci 2013; 136: 223–230.

6.

Salilew-Wondim D, Hölker M, Rings F, Ghanem N, Ulas-Cinar
M, Peippo J, Tholen E, Looft C, Schellander K, Tesfaye D.
Bovine pretransfer endometrium and embryo transcriptome
fingerprints as predictors of pregnancy success after embryo
transfer. Physiol Genomics 2010; 42: 201–218.

16.

Siqueira LG, Torres CA, Souza ED, Monteiro PL Jr, Arashiro
EK, Camargo LS, Fernandes CA, Viana JH. Pregnancy
rates and corpus luteum-related factors affecting pregnancy
establishment in bovine recipients synchronized for fixed-time
embryo transfer. Theriogenology 2009; 72: 949–958.

7.

Ponsuksili S, Murani E, Schwerin M, Schellander K, Tesfaye D,
Wimmers K. Gene expression and DNA-methylation of bovine
pretransfer endometrium depending on its receptivity after in
vitro-produced embryo transfer. PLoS One 2012; 7: e42402.

17.

8.

Corcoran D, Fair T, Park S, Rizos D, Patel OV, Smith GW,
Coussens PM, Ireland JJ, Boland MP, Evans AC et al.
Suppressed expression of genes involved in transcription and
translation in in vitro compared with in vivo cultured bovine
embryos. Reproduction 2006; 131: 651–660.

Breukelman SP, Perényi Z, Taverne MA, Jonker H, van der
Weijden GC, Vos PL, de Ruigh L, Dieleman SJ, Beckers JF,
Szenci O. Characterisation of pregnancy losses after embryo
transfer by measuring plasma progesterone and bovine
pregnancy-associated glycoprotein-1 concentrations. Vet J
2012; 194: 71–76.

18.

Farin PW, Piedrahita JA, Farin CE. Errors in development of
fetuses and placentas from in vitro-produced bovine embryos.
Theriogenology 2006; 65: 178–191.

19.

Numabe T, Oikawa T, Kikuchi T, Horiuchi T. Birth weight and
birth rate of heavy calves conceived by transfer of in vitro or
in vivo produced bovine embryos. Anim Reprod Sci 2000; 64:
13–20.

9.

Gad A, Hoelker M, Besenfelder U, Havlicek V, Cinar U, Rings
F, Held E, Dufort I, Sirard MA, Schellander K et al. Molecular
mechanisms and pathways involved in bovine embryonic
genome activation and their regulation by alternative in vivo
and in vitro culture conditions. Biol Reprod 2012; 87: 100.

10.

Crosier AE, Farin PW, Dykstra MJ, Alexander JE, Farin CE.
Ultrastructural morphometry of bovine compact morulae
produced in vivo or in vitro. Biol Reprod 2000; 62: 1459–1465.

20.

Bonilla L, Block J, Denicol AC, Hansen PJ. Consequences
of transfer of an in vitro-produced embryo for the dam and
resultant calf. J Dairy Sci 2014; 97: 229–239.

11.

Sudano MJ, Santos VG, Tata A, Ferreira CR, Paschoal DM,
Machado R, Buratini J, Eberlin MN, Landim-Alvarenga FD.
Phosphatidylcholine and sphingomyelin profiles vary in Bos
taurus indicus and Bos taurus taurus in vitro- and in vivoproduced blastocysts. Biol Reprod 2012; 87: 130.

21.

Rizos D, Ramirez MA, Pintado B, Lonergan P, Gutierrez-Adan
A. Culture of bovine embryos in intermediate host oviducts
with emphasis on the isolated mouse oviduct. Theriogenology
2010; 73: 777–785.

595

HANSEN et al. / Turk J Vet Anim Sci
22.

Mamo S, Mehta JP, Forde N, McGettigan P, Lonergan
P. Conceptus-endometrium crosstalk during maternal
recognition of pregnancy in cattle. Biol Reprod 2012; 87: 6.

36.

Nahar A, Maki S, Kadokawa H. Suppressed expression of
granulocyte macrophage colony-stimulating factor in oviduct
ampullae of obese cows. Anim Reprod Sci 2013; 139: 1–8.

23.

Hansen PJ, Dobbs KB, Denicol AC. Programming of the
preimplantation embryo by the embryokine colony stimulating
factor 2. Anim Reprod Sci 2014 (in press).

37.

24.

Minten MA, Bilby TR, Bruno RG, Allen CC, Madsen CA,
Wang Z, Sawyer JE, Tibary A, Neibergs HL, Geary TW et
al. Effects of fertility on gene expression and function of the
bovine endometrium. PLoS One 2013; 8: e69444.

Loureiro B, Bonilla L, Block J, Fear JM, Bonilla AQ, Hansen
PJ. Colony-stimulating factor 2 (CSF-2) improves development
and posttransfer survival of bovine embryos produced in vitro.
Endocrinology 2009; 150: 5046–5054.

38.

25.

Yoshioka K, Suzuki C, Iwamura S. Effects of activin A and
follistatin on developmental kinetics of bovine embryos:
cinematographic analysis in a chemically defined medium. J
Reprod Fertil 2000; 118: 119–125.

Denicol AC, Block J, Kelley DE, Pohler KG, Mortensen CJ,
Ortega MS, Hansen PJ. Regulation of WNT signaling by
the antagonist Dickkopf-1 directs lineage commitment and
promotes survival of the preimplantation embryo. FASEB J
2014 (in press).

39.

Sjöblom C, Roberts CT, Wikland M, Robertson SA.
Granulocyte-macrophage colony-stimulating factor alleviates
adverse consequences of embryo culture on fetal growth
trajectory and placental morphogenesis. Endocrinology 2005;
146: 2142–2153.

40.

Ziebe S, Loft A, Povlsen BB, Erb K, Agerholm I, Aasted
M, Gabrielsen A, Hnida C, Zobel DP, Munding B et al. A
randomized clinical trial to evaluate the effect of granulocytemacrophage colony-stimulating factor (GM-CSF) in embryo
culture medium for in vitro fertilization. Fertil Steril 2013; 99:
1600–1609.

41.

Dobbs KB, Khan FA, Sakatani M, Moss JI, Ozawa M, Ealy AD,
Hansen PJ. Regulation of pluripotency of inner cell mass and
growth and differentiation of trophectoderm of the bovine
embryo by colony stimulating factor 2. Biol Reprod 2013; 89:
141.

42.

Fischer-Brown AE, Lindsey BR, Ireland FA, Northey DL,
Monson RL, Clark SG, Wheeler MB, Kesler DJ, Lane SJ, Weigel
KA et al. Embryonic disc development and subsequent viability
of cattle embryos following culture in two media under two
oxygen concentrations. Reprod Fertil Dev 2004; 16: 787–793.

43.

Block J, Fischer-Brown AE, Rodina TM, Ealy AD, Hansen PJ.
The effect of in vitro treatment of bovine embryos with IGF-1
on subsequent development in utero to Day 14 of gestation.
Theriogenology 2007; 68: 153–161.

44.

Loureiro B, Block J, Favoreto MG, Carambula S, Pennington
KA, Ealy AD, Hansen PJ. Consequences of conceptus exposure
to colony-stimulating factor 2 on survival, elongation,
interferon-τ secretion, and gene expression. Reproduction
2011; 141: 617–624.

45.

Dobbs KB, Gagné D, Fournier E, Dufort I, Robert C, Block J,
Sirard MA, Bonilla L, Ealy AD, Loureiro B et al. Sex-specific
developmental programming of the bovine embryo by colony
stimulating factor 2 (CSF2). Reprod Fertil Dev 2014; 26: 160
(abstr).

46.

Loureiro B, Oliveira LJ, Favoreto MG, Hansen PJ. Colonystimulating factor 2 inhibits induction of apoptosis in the
bovine preimplantation embryo. Am J Reprod Immunol 2011;
65: 578–588.

47.

McClure BJ, Hercus TR, Cambareri BA, Woodcock JM, Bagley
CJ, Howlett GJ, Lopez AF. Molecular assembly of the ternary
granulocyte-macrophage colony-stimulating factor receptor
complex. Blood 2003; 101: 1308–1315.

26.

Park JE, Oh HJ, Hong SG, Jang G, Kim MK, Lee BC. Effects of
activin A on the in vitro development and mRNA expression
of bovine embryos cultured in chemically-defined two-step
culture medium. Reprod Domest Anim 2010; 45: 585–593.

27.

Paula-Lopes FF, de Moraes AA, Edwards JL, Justice JE, Hansen
PJ. Regulation of preimplantation development of bovine
embryos by interleukin-1β. Biol Reprod 1998; 59: 1406–1412.

28.

Neira JA, Tainturier D, Peña MA, Martal J. Effect of the
association of IGF-I, IGF-II, bFGF, TGF-β1, GM-CSF, and
LIF on the development of bovine embryos produced in vitro.
Theriogenology 2010; 73: 595–604.

29.

Fields SD, Hansen PJ, Ealy AD. Fibroblast growth factor
requirements for in vitro development of bovine embryos.
Theriogenology 2011; 75: 1466–1475.

30.

Sakagami N, Umeki H, Nishino O, Uchiyama H, Ichikawa K,
Takeshita K, Kaneko E, Akiyama K, Kobayashi S, Tamada H.
Normal calves produced after transfer of embryos cultured in
a chemically defined medium supplemented with epidermal
growth factor and insulin-like growth factor I following ovum
pick up and in vitro fertilization in Japanese black cows. J
Reprod Dev 2012; 58: 140–146.

31.

Metcalf D. The molecular biology and functions of the
granulocyte-macrophage colony-stimulating factors. Blood
1986; 67: 257–267.

32.

Hamilton JA. GM-CSF in inflammation and autoimmunity.
Trends Immunol 2002; 23; 403–408.

33.

Barreda DR, Hanington PC, Belosevic M. Regulation of
myeloid development and function by colony stimulating
factors. Dev Comp Immunol 2004; 28: 509–554.

34.

de Moraes AA, Paula-Lopes FF, Chegini N, Hansen PJ.
Localization of granulocyte-macrophage colony-stimulating
factor in the bovine reproductive tract. J Reprod Immunol
1999; 42: 135–145.

35.

596

Emond V, MacLaren LA, Kimmins S, Arosh JA, Fortier MA,
Lambert RD. Expression of cyclooxygenase-2 and granulocytemacrophage colony-stimulating factor in the endometrial
epithelium of the cow is up-regulated during early pregnancy
and in response to intrauterine infusions of interferon-τ. Biol
Reprod 2004; 70: 54–64.

HANSEN et al. / Turk J Vet Anim Sci
48.

Robertson SA, Sjöblom C, Jasper MJ, Norman RJ, Seamark
RF. Granulocyte-macrophage colony-stimulating factor
promotes glucose transport and blastomere viability in murine
preimplantation embryos. Biol Reprod 2001; 64: 1206–1215.

60.

Pershing RA, Lucy MC, Thatcher WW, Badinga L. Effects of
BST on oviductal and uterine genes encoding components of
the IGF system in lactating dairy cows. J Dairy Sci 2002; 85:
3260–3267.

49.

Sjöblom C, Wikland M, Robertson SA. Granulocytemacrophage colony-stimulating factor (GM-CSF) acts
independently of the beta common subunit of the GMCSF receptor to prevent inner cell mass apoptosis in human
embryos. Biol Reprod 2002; 67: 1817–1823.

61.

McCarthy SD, Roche JF, Forde N. Temporal changes in
endometrial gene expression and protein localization of
members of the IGF family in cattle: effects of progesterone
and pregnancy. Physiol Genomics 2012; 44: 130–140.

62.

50.

Lee K, Redel BK, Spate L, Teson J, Brown AN, Park KW, Walters
E, Samuel M, Murphy CN, Prather RS. Piglets produced from
cloned blastocysts cultured in vitro with GM-CSF. Mol Reprod
Dev 2013; 80: 145–154.

Lonergan P, Rizos D, Gutierrez-Adán A, Moreira PM, Pintado
B, de la Fuente J, Boland MP. Temporal divergence in the
pattern of messenger RNA expression in bovine embryos
cultured from the zygote to blastocyst stage in vitro or in vivo.
Biol Reprod 2003; 69: 1424–1431.

51.

Dhar-Mascareno M, Chen J, Zhang RH, Cárcamo JM, Golde
DW. Granulocyte-macrophage colony-stimulating factor
signals for increased glucose transport via phosphatidylinositol
3-kinase- and hydrogen peroxide-dependent mechanisms. J
Biol Chem 2003; 278: 11107–11114.

63.

Murillo-Cuesta S, Rodríguez-de la Rosa L, Cediel R, Lassaletta
L, Varela-Nieto I. The role of insulin-like growth factor-I in the
physiopathology of hearing. Front Mol Neurosci 2011; 4: 11.

64.

Matsui M, Takahashi Y, Hishinuma M, Kanagawa H.
Stimulation of the development of bovine embryos by insulin
and insulin-like growth factor-I (IGF-I) is mediated through
the IGF-I receptor. Theriogenology 1997; 48: 605–616.

65.

Moreira F, Paula-Lopes FF, Hansen PJ, Badinga L, Thatcher
WW. Effects of growth hormone and insulin-like growth
factor-I on development of in vitro derived bovine embryos.
Theriogenology 2002; 57: 895–907.

66.

Byrne AT, Southgate J, Brison DR, Leese HJ. Regulation of
apoptosis in the bovine blastocyst by insulin and the insulinlike growth factor (IGF) superfamily. Mol Reprod Dev 2002;
62: 489–495.

67.

Sirisathien S, Hernandez-Fonseca HJ, Brackett BG. Influences
of epidermal growth factor and insulin-like growth factor-I on
bovine blastocyst development in vitro. Anim Reprod Sci 2003;
77: 21–32.

68.

Wang LM, Feng HL, Ma YZ, Cang M, Li HJ, Yan Z, Zhou P,
Wen JX, Bou S, Liu DJ. Expression of IGF receptors and its
ligands in bovine oocytes and preimplantation embryos. Anim
Reprod Sci 2009; 114: 99–108.

69.

Bonilla AQ, Ozawa M, Hansen PJ. Timing and dependence
upon mitogen-activated protein kinase signaling for prodevelopmental actions of insulin-like growth factor 1 on the
preimplantation bovine embryo. Growth Horm IGF Res 2011;
21: 107–111.

70.

Jousan FD, Hansen PJ. Insulin-like growth factor-I promotes
resistance of bovine preimplantation embryos to heat shock
through actions independent of its anti-apoptotic actions
requiring PI3K signaling. Mol Reprod Dev 2007; 74: 189–196.

71.

Jousan FD, Oliveira LJ, Hansen PJ. Short-term culture of in
vitro produced bovine preimplantation embryos with insulinlike growth factor-I prevents heat shock-induced apoptosis
through activation of the Phosphatidylinositol 3-Kinase/Akt
pathway. Mol Reprod Dev 2008; 75: 681–688.

72.

Moss JI, Pontes E, Hansen PJ. Insulin-like growth factor-1
protects preimplantation embryos from anti-developmental
actions of menadione. Arch Toxicol 2009; 83: 1001–1007.

52.

Philippou A, Maridaki M, Pneumaticos S, Koutsilieris M.
The complexity of the IGF1 gene splicing, post-translational
modification and bioactivity. Mol Med 2014; 20: 202–214.

53.

Fernandez AM, Torres-Alemán I. The many faces of insulinlike peptide signalling in the brain. Nat Rev Neurosci 2012; 13:
225–239.

54.

Lucy MC, Thatcher WW, Collier RJ, Simmen FA, Ko Y, Savio
JD, Badinga L. Effects of somatotropin on the conceptus,
uterus, and ovary during maternal recognition of pregnancy in
cattle. Domest Anim Endocrinol 1995; 12: 73–82.

55.

Bilby TR, Guzeloglu A, Kamimura S, Pancarci SM, Michel F,
Head HH, Thatcher WW. Pregnancy and bovine somatotropin
in nonlactating dairy cows: I. Ovarian, conceptus, and insulinlike growth factor system responses. J Dairy Sci 2004; 87:
3256–3267.

56.

57.

58.

59.

Pushpakumara PG, Robinson RS, Demmers KJ, Mann GE,
Sinclair KD, Webb R, Wathes DC. Expression of the insulinlike growth factor (IGF) system in the bovine oviduct at oestrus
and during early pregnancy. Reproduction 2002; 123: 859–868.
Swangchan-Uthai T, Walsh SW, Alexander SL, Cheng Z, Crowe
MA, Evans AC, Wathes DC. Comparison of mRNA for IGFs
and their binding proteins in the oviduct during the perioestrous period between dairy heifers and lactating cows.
Reproduction 2011; 142: 457–465.
Schmidt A, Einspanier R, Amselgruber W, Sinowatz F, Schams
D. Expression of insulin-like growth factor 1 (IGF-1) in the
bovine oviduct during the oestrous cycle. Exp Clin Endocrinol
1994; 102: 364–369.
Kirby CJ, Thatcher WW, Collier RJ, Simmen FA, Lucy MC.
Effects of growth hormone and pregnancy on expression of
growth hormone receptor, insulin-like growth factor-I, and
insulin-like growth factor binding protein-2 and -3 genes in
bovine uterus, ovary, and oviduct. Biol Reprod 1996; 55: 996–
1002.

597

HANSEN et al. / Turk J Vet Anim Sci
73.

Jousan FD, Hansen PJ. Insulin-like growth factor-I as a survival
factor for the bovine preimplantation embryo exposed to heat
shock. Biol Reprod 2004; 71: 1665–1670.

74.

Bonilla AQ, Oliveira LJ, Ozawa M, Newsom EM, Lucy MC,
Hansen PJ. Developmental changes in thermoprotective
actions of insulin-like growth factor-1 on the preimplantation
bovine embryo. Mol Cell Endocrinol 2011; 332: 170–179.

83.

De A. Wnt/Ca2+ signaling pathway: a brief overview. Acta
Biochem Biophys Sin 2011; 43: 745–756.

84.

Van Amerongen, R, Nusse R. Towards an integrated view of
Wnt signaling in development. Development 2009; 136: 3205–
3214.

85.

Chien, AJ, Conrad WH, Moon RT. A Wnt survival guide: from
flies to human disease. J Invest Dermatol 2009; 129: 1614–1627.

75.

Makarevich AV, Kubovičová E, Hegedušová Z, Pivko J, Louda
F. Post-thaw culture in presence of insulin-like growth factor I
improves the quality of cattle cryopreserved embryos. Zygote
2012; 20: 97–102.

86.

76.

Memili E, First NL. Zygotic and embryonic gene expression
in cow: a review of timing and mechanisms of early gene
expression as compared with other species. Zygote 2000; 8:
87–96.

Pinzone JJ, Hall BM, Thudi NK, Vonau M, Qiang YW,
Rosol TJ, Shaughnessy JD Jr. The role of Dickkopf-1 in bone
development, homeostasis, and disease. Blood 2009; 113: 517–
525.

87.

77.

Block J, Drost M, Monson RL, Rutledge JJ, Rivera RM, PaulaLopes FF, Ocon OM, Krininger CE 3rd, Liu J, Hansen PJ. Use
of insulin-like growth factor-I during embryo culture and
treatment of recipients with gonadotropin-releasing hormone
to increase pregnancy rates following the transfer of in vitroproduced embryos to heat-stressed, lactating cows. J Anim Sci
2003; 81: 1590–1602.

Denicol AC, Dobbs KB, McLean KM, Carambula SF, Loureiro
B, Hansen PJ. Canonical WNT signaling regulates development
of bovine embryos to the blastocyst stage. Sci Rept 2013; 3:
1266.

88.

Cerri RL, Thompson IM, Kim IH, Ealy AD, Hansen PJ, Staples
CR, Li JL, Santos JE, Thatcher WW. Effects of lactation and
pregnancy on gene expression of endometrium of Holstein
cows at day 17 of the estrous cycle or pregnancy. J Dairy Sci
2012; 95: 5657–5675.

89.

Li Y, Lu W, King TD, Liu CC, Bijur GN, Bu G. Dkk1 stabilizes
Wnt co-receptor LRP6: implication for Wnt ligand-induced
LRP6 down-regulation. PLoS One 2010; 5: e11014.

90.

Nakamura T, Nakamura T, Matsumoto K. The functions and
possible significance of Kremen as the gatekeeper of Wnt
signalling in development and pathology. J Cell Mol Med 2008;
12: 391–408.

91.

Caneparo L, Huang YL, Staudt N, Tada M, Ahrendt R,
Kazanskaya O, Niehrs C, Houart C. Dickkopf-1 regulates
gastrulation movements by coordinated modulation of Wnt/
beta catenin and Wnt/PCP activities, through interaction with
the Dally-like homolog Knypek. Genes Dev 2007; 21: 465–480.

92.

Killick R, Ribe EM, Al-Shawi R, Malik B, Hooper C, Fernandes
C, Dobson R, Nolan PM, Lourdusamy A, Furney S et al.
Clusterin regulates β-amyloid toxicity via Dickkopf-1-driven
induction of the wnt-PCP-JNK pathway. Mol Psychiatry 2014;
19: 88–98.

93.

Krause U, Ryan DM, Clough BH, Gregory CA. An unexpected
role for a Wnt-inhibitor: Dickkopf-1 triggers a novel cancer
survival mechanism through modulation of aldehydedehydrogenase-1 activity. Cell Death Dis 2014; 5: e1093.

78.

79.

Block J, Hansen PJ. Interaction between season and culture
with insulin-like growth factor-1 on survival of in vitro
produced embryos following transfer to lactating dairy cows.
Theriogenology 2007; 67: 1518–1529.
Ealy AD, Drost M, Hansen PJ. Developmental changes in
embryonic resistance to adverse effects of maternal heat stress
in cows. J Dairy Sci 1993; 76: 2899–2905.

80.

Hansen PJ. Exploitation of genetic and physiological
determinants of embryonic resistance to elevated temperature
to improve embryonic survival in dairy cattle during heat
stress. Theriogenology 2007; 68 (Suppl. 1): S242–S249.

81.

Block J, Wrenzycki C, Niemann H, Herrmann D, Hansen
PJ. Effects of insulin-like growth factor-1 on cellular and
molecular characteristics of bovine blastocysts produced in
vitro. Mol Reprod Dev 2008; 75: 895–903.

82.

Moreira F, Badinga L, Burnley C, Thatcher WW. Bovine
somatotropin increases embryonic development in
superovulated cows and improves post-transfer pregnancy
rates when given to lactating recipient cows. Theriogenology
2002; 57: 1371–1387.

598

